期刊文献+

小儿肝母细胞瘤的诊断与治疗 被引量:15

原文传递
导出
摘要 现根据北美和欧洲肝母细胞瘤研究经验结合我国的临床实践,着重讨论肝母细胞瘤的诊断路径及治疗策略,以期提高对肝母细胞瘤的治疗水平。
作者 王焕民
出处 《中华实用儿科临床杂志》 CAS CSCD 北大核心 2013年第3期166-167,共2页 Chinese Journal of Applied Clinical Pediatrics
  • 相关文献

参考文献8

  • 1张金哲.现代小儿肿瘤外科学[M]北京:科学出版社,2009408-427.
  • 2Darbari A,Sabin KM,Shapiro CN. Epidemiology of primary hepatic malignancies in U.S.children[J].Hepatology,2003,(03):560-566.
  • 3Leal-Leal CA,Imaz-Olguín V. Hepatoblastoma.Clinical experience at a single institution using the Siopel staging system[J].Annals of Hematology,2010,(01):75-79.
  • 4Meyers RL,Rowland JR,Krailo M. Predictive power of pretreatment prognostic factors in children with hepatoblastoma:a report from the Children's Oncology Group[J].Pediatric Blood & Cancer,2009,(06):1016-1022.
  • 5Shukla PJ,Barreto SG,Qureshi SS. Hepatoblastoma:a single institutional experience of 18 cases[J].Pediatric Surgery International,2008,(07):799-802.doi:10.1007/s00383-008-2169-x.
  • 6Pham TH,Iqbal CW,GramsJM. Outcomes of primary cancer in children:an appraisal of experience[J].Journal of Pediatrics,2007,(05):834-839.
  • 7Wang LL,Filippi RZ,Zurakowski D. Effects of neoadjuvant chemotherapy on hepatoblastoma:a morphologic and immunohistochemical study[J].American Journal of Surgical Pathology,2010,(03):287-299.
  • 8Lovvon H N 3rd,Ayers D,Zhao Z. Defining hepatoblastoma responsiveness to induction therapy as measured by tumor volume and surum alpha-fetopmtein kinetics[J].Journal of Pediatric Surgery,2010,(01):121-129.

同被引文献112

  • 1Guerrini R,Rosati A,Giordano F. The medical and surgical treatment of tumoral seizures:current and future perspectives[J].EPILEPSIA,2013,(09):84-90.
  • 2Sobin LH,Gospodarmwicz MK,Wittekind CH. TNM Classification of Malignant Tumours[M].Oxford:Wiley-Blackwell,2009.1-21.
  • 3Park CK,Kim JH,Nam DH. A practical scoring system to determine whether to proceed with surgical resection in recurrent glioblastoma[J].Neuro Oncol,2013,(08):1096-1101.
  • 4Uchida S,Shimada Y,Watanabe G. In esophagealsquamous cell carcinoma vascular endothelial growth factoris associated with p53 mutation,advanced stage and poorprognosis[J].British Journal of Cancer,1998,(10):1704-1709.
  • 5Foote RL,Weidner N,Harris J. Evaluation of tumor angiogenesis measured with microvessel density (MVD) as aprognostic indicator in nasopharyngeal carcinoma:results of RTOG 9505[J].International Journal of Radiation Oncology Biology Physics,2005,(03):745-753.
  • 6刘复生;刘彤华.肿瘤病理学[M]北京:北京医科大学中国协和医科大学联合出版社,199712-15.
  • 7Goel HL,Mercurio AM. VEGF targets the tumour cell[J].Nature Reviews Cancer,2013,(12):871-882.
  • 8Hernandez SL,Banerjee D,Garcia A. Notch and VEGF pathways play distinct but complementary roles in tumor angiogenesis[J].Vasc Cell,2013,(01):17.
  • 9Peiris-Pagès M. The role of VEGF 165b in pathophysiology[J].Cell Adh Migr,2012,(06):561-568.
  • 10Glade Bender J,Blaney SM,Borinstein S. A phase Ⅰ trial and pharmacokinetic study of aflibercept (VEGF Trap) in children with refractory solid tumors:a children's oncology group phase Ⅰ consortium report[J].Clinical Cancer Research,2012,(18):5081-5089.

引证文献15

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部